U.S. Markets open in 4 hrs 47 mins

Cerebain Biotech Corp. (CBBT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0450-0.0057 (-11.33%)
At close: 3:59PM EDT

Cerebain Biotech Corp.

600 Anton Boulevard
Suite 1100
Costa Mesa, CA 92626
United States

Full Time Employees2

Key Executives

NameTitlePayExercisedYear Born
Mr. Eric Andre ClemonsPres, CEO & Director231.93kN/A1972
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cerebain Biotech Corp., a biomedical company, focuses on the discovery of products for the treatment of Alzheimer's disease. Its products would include medical device solutions, as well as synthetic drug solutions. The company was formerly known as Discount Dental Materials, Inc. and changed its name to Cerebain Biotech Corp. in June 2014. Cerebain Biotech Corp. was incorporated in 2007 and is headquartered in Costa Mesa, California.

Corporate Governance

Cerebain Biotech Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.